Cytomegalovirus infection in malignant pleural mesothelioma

Human cytomegalovirus (HCMV) is a highly prevalent herpes virus which persists as a latent infection and has been detected in several different tumor types. HCMV disease is rare but may occur in high-risk settings, often manifesting as a pulmonary infection. To date HCMV has not been investigated in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-08, Vol.16 (8), p.e0254136-e0254136
Hauptverfasser: Hunter-Schlichting, DeVon, Kelsey, Karl T, Demmer, Ryan, Patel, Manish, Bueno, Raphael, Christensen, Brock, Fujioka, Naomi, Kolarseri, Deepa, Nelson, Heather H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0254136
container_issue 8
container_start_page e0254136
container_title PloS one
container_volume 16
creator Hunter-Schlichting, DeVon
Kelsey, Karl T
Demmer, Ryan
Patel, Manish
Bueno, Raphael
Christensen, Brock
Fujioka, Naomi
Kolarseri, Deepa
Nelson, Heather H
description Human cytomegalovirus (HCMV) is a highly prevalent herpes virus which persists as a latent infection and has been detected in several different tumor types. HCMV disease is rare but may occur in high-risk settings, often manifesting as a pulmonary infection. To date HCMV has not been investigated in malignant pleural mesothelioma (MPM). In a consecutive case series of 144 MPM patients we evaluated two biomarkers of HCMV: IgG serostatus (defined as positive and negative) and DNAemia (>100 copies/mL of cell free HCMV DNA in serum). Approximately half of the MPM patient population was HCMV IgG seropositive (51%). HCMV DNAemia was highly prevalent (79%) in MPM and independent of IgG serostatus. DNAemia levels consistent with high level current infection (>1000 copies/mL serum) were present in 41% of patients. Neither IgG serostatus nor DNAemia were associated with patient survival. In tissues, we observed that HCMV DNA was present in 48% of tumors (n = 40) and only 29% of normal pleural tissue obtained from individuals without malignancy (n = 21). Our results suggest nearly half of MPM patients have a high level current HCMV infection at the time of treatment and that pleural tissue may be a reservoir for latent HCMV infection. These findings warrant further investigation to determine the full spectrum of pulmonary infections in MPM patients, and whether treatment for high level current HCMV infection may improve patient outcomes.
doi_str_mv 10.1371/journal.pone.0254136
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2560814397</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A671834390</galeid><doaj_id>oai_doaj_org_article_fb13723d960d4c7a8854dba020916b2b</doaj_id><sourcerecordid>A671834390</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-b9c34500ab5cdfcb906714e7a6599ce5b0e4dcbc0df9f60a6b8130b12c1e486f3</originalsourceid><addsrcrecordid>eNqNkl1r2zAUhs3YWNts_2BsgUHZLpJJlixLDAYl7CNQKOzrVkjysaMgW6kll_XfT2ncEo9eDF1IyM955fOeN8teYbTEpMQftn7oO-WWO9_BEuUFxYQ9yU6xIPmC5Yg8PTqfZGchbBEqCGfseXZCKOGk5MVp9nF1G30LjXL-xvZDmNuuBhOt79Jp3ipnm051cb5zMPTKzVsIPm7AWd-qF9mzWrkAL8d9lv368vnn6tvi8urrenVxuTBM5HGhhSG0QEjpwlS10QKxElMoFSuEMFBoBLQy2qCqFjVDimmOCdI4NxgoZzWZZW8Oujvngxz7DjIvGOKYElEmYn0gKq-2ctfbVvW30isr7y5830jVR2scyFon93JSCYYqakrFeUErrVCOBGY610nr0_jaoFuoDHQxNT4RnX7p7EY2_kZywlCRLJ9l70aB3l8PEKJsbTDgnOrAD3f_jSkniJKEvv0Hfby7kUpTApkG5NO7Zi8qL5KVPE1ToEQtH6HSqqC1JoWktul-UvB-UpCYCH9io4YQ5PrH9_9nr35P2fMjdgPKxU3wbtiHKkxBegBN70PooX4wGSO5z_i9G3KfcTlmPJW9Ph7QQ9F9qMlfg9L2nQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2560814397</pqid></control><display><type>article</type><title>Cytomegalovirus infection in malignant pleural mesothelioma</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Hunter-Schlichting, DeVon ; Kelsey, Karl T ; Demmer, Ryan ; Patel, Manish ; Bueno, Raphael ; Christensen, Brock ; Fujioka, Naomi ; Kolarseri, Deepa ; Nelson, Heather H</creator><contributor>Spencer, Juliet V.</contributor><creatorcontrib>Hunter-Schlichting, DeVon ; Kelsey, Karl T ; Demmer, Ryan ; Patel, Manish ; Bueno, Raphael ; Christensen, Brock ; Fujioka, Naomi ; Kolarseri, Deepa ; Nelson, Heather H ; Spencer, Juliet V.</creatorcontrib><description>Human cytomegalovirus (HCMV) is a highly prevalent herpes virus which persists as a latent infection and has been detected in several different tumor types. HCMV disease is rare but may occur in high-risk settings, often manifesting as a pulmonary infection. To date HCMV has not been investigated in malignant pleural mesothelioma (MPM). In a consecutive case series of 144 MPM patients we evaluated two biomarkers of HCMV: IgG serostatus (defined as positive and negative) and DNAemia (&gt;100 copies/mL of cell free HCMV DNA in serum). Approximately half of the MPM patient population was HCMV IgG seropositive (51%). HCMV DNAemia was highly prevalent (79%) in MPM and independent of IgG serostatus. DNAemia levels consistent with high level current infection (&gt;1000 copies/mL serum) were present in 41% of patients. Neither IgG serostatus nor DNAemia were associated with patient survival. In tissues, we observed that HCMV DNA was present in 48% of tumors (n = 40) and only 29% of normal pleural tissue obtained from individuals without malignancy (n = 21). Our results suggest nearly half of MPM patients have a high level current HCMV infection at the time of treatment and that pleural tissue may be a reservoir for latent HCMV infection. These findings warrant further investigation to determine the full spectrum of pulmonary infections in MPM patients, and whether treatment for high level current HCMV infection may improve patient outcomes.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0254136</identifier><identifier>PMID: 34383785</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Age ; Aged ; Antibodies, Viral - blood ; Asbestos ; Biobanks ; Biology and life sciences ; Biomarkers ; Complications and side effects ; Consent ; Cytomegalovirus ; Cytomegalovirus - metabolism ; Cytomegalovirus infections ; Cytomegalovirus Infections - blood ; Cytomegalovirus Infections - mortality ; Deoxyribonucleic acid ; Diagnosis ; Disease-Free Survival ; DNA ; DNA, Viral - blood ; Epidemiology ; Female ; Hematology ; Histology ; Hospitals ; Humans ; Immunoglobulin G ; Immunoglobulin G - blood ; Infections ; Laboratories ; Latent infection ; Lung cancer ; Male ; Malignancy ; Medical prognosis ; Medicine and Health Sciences ; Mesothelioma ; Mesothelioma, Malignant - blood ; Mesothelioma, Malignant - mortality ; Mesothelioma, Malignant - virology ; Metastasis ; Middle Aged ; Pathology ; Patients ; Pleural Neoplasms - blood ; Pleural Neoplasms - mortality ; Pleural Neoplasms - virology ; Pneumonia ; Pneumonia, Viral - blood ; Pneumonia, Viral - mortality ; Pneumonia, Viral - virology ; Prognosis ; Questionnaires ; Retrospective Studies ; Risk factors ; Serology ; Survival Rate ; Thoracic surgery ; Tissues ; Transplants &amp; implants ; Tumors ; Viral infections ; Viruses ; Womens health</subject><ispartof>PloS one, 2021-08, Vol.16 (8), p.e0254136-e0254136</ispartof><rights>COPYRIGHT 2021 Public Library of Science</rights><rights>2021 Hunter-Schlichting et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 Hunter-Schlichting et al 2021 Hunter-Schlichting et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-b9c34500ab5cdfcb906714e7a6599ce5b0e4dcbc0df9f60a6b8130b12c1e486f3</citedby><cites>FETCH-LOGICAL-c692t-b9c34500ab5cdfcb906714e7a6599ce5b0e4dcbc0df9f60a6b8130b12c1e486f3</cites><orcidid>0000-0002-3231-5491 ; 0000-0002-2986-9602</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360519/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360519/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,861,882,2096,2915,23847,27905,27906,53772,53774,79349,79350</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34383785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Spencer, Juliet V.</contributor><creatorcontrib>Hunter-Schlichting, DeVon</creatorcontrib><creatorcontrib>Kelsey, Karl T</creatorcontrib><creatorcontrib>Demmer, Ryan</creatorcontrib><creatorcontrib>Patel, Manish</creatorcontrib><creatorcontrib>Bueno, Raphael</creatorcontrib><creatorcontrib>Christensen, Brock</creatorcontrib><creatorcontrib>Fujioka, Naomi</creatorcontrib><creatorcontrib>Kolarseri, Deepa</creatorcontrib><creatorcontrib>Nelson, Heather H</creatorcontrib><title>Cytomegalovirus infection in malignant pleural mesothelioma</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Human cytomegalovirus (HCMV) is a highly prevalent herpes virus which persists as a latent infection and has been detected in several different tumor types. HCMV disease is rare but may occur in high-risk settings, often manifesting as a pulmonary infection. To date HCMV has not been investigated in malignant pleural mesothelioma (MPM). In a consecutive case series of 144 MPM patients we evaluated two biomarkers of HCMV: IgG serostatus (defined as positive and negative) and DNAemia (&gt;100 copies/mL of cell free HCMV DNA in serum). Approximately half of the MPM patient population was HCMV IgG seropositive (51%). HCMV DNAemia was highly prevalent (79%) in MPM and independent of IgG serostatus. DNAemia levels consistent with high level current infection (&gt;1000 copies/mL serum) were present in 41% of patients. Neither IgG serostatus nor DNAemia were associated with patient survival. In tissues, we observed that HCMV DNA was present in 48% of tumors (n = 40) and only 29% of normal pleural tissue obtained from individuals without malignancy (n = 21). Our results suggest nearly half of MPM patients have a high level current HCMV infection at the time of treatment and that pleural tissue may be a reservoir for latent HCMV infection. These findings warrant further investigation to determine the full spectrum of pulmonary infections in MPM patients, and whether treatment for high level current HCMV infection may improve patient outcomes.</description><subject>Age</subject><subject>Aged</subject><subject>Antibodies, Viral - blood</subject><subject>Asbestos</subject><subject>Biobanks</subject><subject>Biology and life sciences</subject><subject>Biomarkers</subject><subject>Complications and side effects</subject><subject>Consent</subject><subject>Cytomegalovirus</subject><subject>Cytomegalovirus - metabolism</subject><subject>Cytomegalovirus infections</subject><subject>Cytomegalovirus Infections - blood</subject><subject>Cytomegalovirus Infections - mortality</subject><subject>Deoxyribonucleic acid</subject><subject>Diagnosis</subject><subject>Disease-Free Survival</subject><subject>DNA</subject><subject>DNA, Viral - blood</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Hematology</subject><subject>Histology</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Immunoglobulin G</subject><subject>Immunoglobulin G - blood</subject><subject>Infections</subject><subject>Laboratories</subject><subject>Latent infection</subject><subject>Lung cancer</subject><subject>Male</subject><subject>Malignancy</subject><subject>Medical prognosis</subject><subject>Medicine and Health Sciences</subject><subject>Mesothelioma</subject><subject>Mesothelioma, Malignant - blood</subject><subject>Mesothelioma, Malignant - mortality</subject><subject>Mesothelioma, Malignant - virology</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Pathology</subject><subject>Patients</subject><subject>Pleural Neoplasms - blood</subject><subject>Pleural Neoplasms - mortality</subject><subject>Pleural Neoplasms - virology</subject><subject>Pneumonia</subject><subject>Pneumonia, Viral - blood</subject><subject>Pneumonia, Viral - mortality</subject><subject>Pneumonia, Viral - virology</subject><subject>Prognosis</subject><subject>Questionnaires</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Serology</subject><subject>Survival Rate</subject><subject>Thoracic surgery</subject><subject>Tissues</subject><subject>Transplants &amp; implants</subject><subject>Tumors</subject><subject>Viral infections</subject><subject>Viruses</subject><subject>Womens health</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl1r2zAUhs3YWNts_2BsgUHZLpJJlixLDAYl7CNQKOzrVkjysaMgW6kll_XfT2ncEo9eDF1IyM955fOeN8teYbTEpMQftn7oO-WWO9_BEuUFxYQ9yU6xIPmC5Yg8PTqfZGchbBEqCGfseXZCKOGk5MVp9nF1G30LjXL-xvZDmNuuBhOt79Jp3ipnm051cb5zMPTKzVsIPm7AWd-qF9mzWrkAL8d9lv368vnn6tvi8urrenVxuTBM5HGhhSG0QEjpwlS10QKxElMoFSuEMFBoBLQy2qCqFjVDimmOCdI4NxgoZzWZZW8Oujvngxz7DjIvGOKYElEmYn0gKq-2ctfbVvW30isr7y5830jVR2scyFon93JSCYYqakrFeUErrVCOBGY610nr0_jaoFuoDHQxNT4RnX7p7EY2_kZywlCRLJ9l70aB3l8PEKJsbTDgnOrAD3f_jSkniJKEvv0Hfby7kUpTApkG5NO7Zi8qL5KVPE1ToEQtH6HSqqC1JoWktul-UvB-UpCYCH9io4YQ5PrH9_9nr35P2fMjdgPKxU3wbtiHKkxBegBN70PooX4wGSO5z_i9G3KfcTlmPJW9Ph7QQ9F9qMlfg9L2nQ</recordid><startdate>20210812</startdate><enddate>20210812</enddate><creator>Hunter-Schlichting, DeVon</creator><creator>Kelsey, Karl T</creator><creator>Demmer, Ryan</creator><creator>Patel, Manish</creator><creator>Bueno, Raphael</creator><creator>Christensen, Brock</creator><creator>Fujioka, Naomi</creator><creator>Kolarseri, Deepa</creator><creator>Nelson, Heather H</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3231-5491</orcidid><orcidid>https://orcid.org/0000-0002-2986-9602</orcidid></search><sort><creationdate>20210812</creationdate><title>Cytomegalovirus infection in malignant pleural mesothelioma</title><author>Hunter-Schlichting, DeVon ; Kelsey, Karl T ; Demmer, Ryan ; Patel, Manish ; Bueno, Raphael ; Christensen, Brock ; Fujioka, Naomi ; Kolarseri, Deepa ; Nelson, Heather H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-b9c34500ab5cdfcb906714e7a6599ce5b0e4dcbc0df9f60a6b8130b12c1e486f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age</topic><topic>Aged</topic><topic>Antibodies, Viral - blood</topic><topic>Asbestos</topic><topic>Biobanks</topic><topic>Biology and life sciences</topic><topic>Biomarkers</topic><topic>Complications and side effects</topic><topic>Consent</topic><topic>Cytomegalovirus</topic><topic>Cytomegalovirus - metabolism</topic><topic>Cytomegalovirus infections</topic><topic>Cytomegalovirus Infections - blood</topic><topic>Cytomegalovirus Infections - mortality</topic><topic>Deoxyribonucleic acid</topic><topic>Diagnosis</topic><topic>Disease-Free Survival</topic><topic>DNA</topic><topic>DNA, Viral - blood</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Hematology</topic><topic>Histology</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Immunoglobulin G</topic><topic>Immunoglobulin G - blood</topic><topic>Infections</topic><topic>Laboratories</topic><topic>Latent infection</topic><topic>Lung cancer</topic><topic>Male</topic><topic>Malignancy</topic><topic>Medical prognosis</topic><topic>Medicine and Health Sciences</topic><topic>Mesothelioma</topic><topic>Mesothelioma, Malignant - blood</topic><topic>Mesothelioma, Malignant - mortality</topic><topic>Mesothelioma, Malignant - virology</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Pathology</topic><topic>Patients</topic><topic>Pleural Neoplasms - blood</topic><topic>Pleural Neoplasms - mortality</topic><topic>Pleural Neoplasms - virology</topic><topic>Pneumonia</topic><topic>Pneumonia, Viral - blood</topic><topic>Pneumonia, Viral - mortality</topic><topic>Pneumonia, Viral - virology</topic><topic>Prognosis</topic><topic>Questionnaires</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Serology</topic><topic>Survival Rate</topic><topic>Thoracic surgery</topic><topic>Tissues</topic><topic>Transplants &amp; implants</topic><topic>Tumors</topic><topic>Viral infections</topic><topic>Viruses</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hunter-Schlichting, DeVon</creatorcontrib><creatorcontrib>Kelsey, Karl T</creatorcontrib><creatorcontrib>Demmer, Ryan</creatorcontrib><creatorcontrib>Patel, Manish</creatorcontrib><creatorcontrib>Bueno, Raphael</creatorcontrib><creatorcontrib>Christensen, Brock</creatorcontrib><creatorcontrib>Fujioka, Naomi</creatorcontrib><creatorcontrib>Kolarseri, Deepa</creatorcontrib><creatorcontrib>Nelson, Heather H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hunter-Schlichting, DeVon</au><au>Kelsey, Karl T</au><au>Demmer, Ryan</au><au>Patel, Manish</au><au>Bueno, Raphael</au><au>Christensen, Brock</au><au>Fujioka, Naomi</au><au>Kolarseri, Deepa</au><au>Nelson, Heather H</au><au>Spencer, Juliet V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytomegalovirus infection in malignant pleural mesothelioma</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2021-08-12</date><risdate>2021</risdate><volume>16</volume><issue>8</issue><spage>e0254136</spage><epage>e0254136</epage><pages>e0254136-e0254136</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Human cytomegalovirus (HCMV) is a highly prevalent herpes virus which persists as a latent infection and has been detected in several different tumor types. HCMV disease is rare but may occur in high-risk settings, often manifesting as a pulmonary infection. To date HCMV has not been investigated in malignant pleural mesothelioma (MPM). In a consecutive case series of 144 MPM patients we evaluated two biomarkers of HCMV: IgG serostatus (defined as positive and negative) and DNAemia (&gt;100 copies/mL of cell free HCMV DNA in serum). Approximately half of the MPM patient population was HCMV IgG seropositive (51%). HCMV DNAemia was highly prevalent (79%) in MPM and independent of IgG serostatus. DNAemia levels consistent with high level current infection (&gt;1000 copies/mL serum) were present in 41% of patients. Neither IgG serostatus nor DNAemia were associated with patient survival. In tissues, we observed that HCMV DNA was present in 48% of tumors (n = 40) and only 29% of normal pleural tissue obtained from individuals without malignancy (n = 21). Our results suggest nearly half of MPM patients have a high level current HCMV infection at the time of treatment and that pleural tissue may be a reservoir for latent HCMV infection. These findings warrant further investigation to determine the full spectrum of pulmonary infections in MPM patients, and whether treatment for high level current HCMV infection may improve patient outcomes.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>34383785</pmid><doi>10.1371/journal.pone.0254136</doi><tpages>e0254136</tpages><orcidid>https://orcid.org/0000-0002-3231-5491</orcidid><orcidid>https://orcid.org/0000-0002-2986-9602</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2021-08, Vol.16 (8), p.e0254136-e0254136
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_2560814397
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Age
Aged
Antibodies, Viral - blood
Asbestos
Biobanks
Biology and life sciences
Biomarkers
Complications and side effects
Consent
Cytomegalovirus
Cytomegalovirus - metabolism
Cytomegalovirus infections
Cytomegalovirus Infections - blood
Cytomegalovirus Infections - mortality
Deoxyribonucleic acid
Diagnosis
Disease-Free Survival
DNA
DNA, Viral - blood
Epidemiology
Female
Hematology
Histology
Hospitals
Humans
Immunoglobulin G
Immunoglobulin G - blood
Infections
Laboratories
Latent infection
Lung cancer
Male
Malignancy
Medical prognosis
Medicine and Health Sciences
Mesothelioma
Mesothelioma, Malignant - blood
Mesothelioma, Malignant - mortality
Mesothelioma, Malignant - virology
Metastasis
Middle Aged
Pathology
Patients
Pleural Neoplasms - blood
Pleural Neoplasms - mortality
Pleural Neoplasms - virology
Pneumonia
Pneumonia, Viral - blood
Pneumonia, Viral - mortality
Pneumonia, Viral - virology
Prognosis
Questionnaires
Retrospective Studies
Risk factors
Serology
Survival Rate
Thoracic surgery
Tissues
Transplants & implants
Tumors
Viral infections
Viruses
Womens health
title Cytomegalovirus infection in malignant pleural mesothelioma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A23%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytomegalovirus%20infection%20in%20malignant%20pleural%20mesothelioma&rft.jtitle=PloS%20one&rft.au=Hunter-Schlichting,%20DeVon&rft.date=2021-08-12&rft.volume=16&rft.issue=8&rft.spage=e0254136&rft.epage=e0254136&rft.pages=e0254136-e0254136&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0254136&rft_dat=%3Cgale_plos_%3EA671834390%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2560814397&rft_id=info:pmid/34383785&rft_galeid=A671834390&rft_doaj_id=oai_doaj_org_article_fb13723d960d4c7a8854dba020916b2b&rfr_iscdi=true